Lawrence Blatt - Chief Executive Officer, Director at Aligos Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Stock Symbol
ALGS on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Lawrence Blatt since 12/17/2023

Holdings reported by Lawrence Blatt for Aligos Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1.85M $1.4M $0.76 Oct 25, 2023 Direct
Common Stock 18.5K $14K $0.76 Oct 25, 2023 Indirect
Warrants (Right to Buy) 305K Oct 25, 2023 Direct Common Stock
Stock Option (Right to Buy) 33.9K Sep 4, 2024 Direct Common Stock

Transactions reported by Lawrence Blatt for Aligos Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.